Inclusion Criteria:  Diagnosis of T2DM for minimum of 3 months defined as fasting glucose greater than or equal to 120 mg/dL, hemoglobin A1C (HbA1C) ≥6.5% Body mass index (BMI) >25 Willing to give written informed consent and able to understand, to participate in and to comply with the study requirements.  Exclusion Criteria:  Treatment with anticoagulation Treatment with SGLT-2 inhibitor HbA1c >9.5% within the last 3 months Systolic blood pressure less than 120mm Hg History of genital mycotic infections: more than one genital mycotic infection in the past two years History of recurrent urinary tract infections: history of chronic cystitis and/or recurrent urinary tract infections (3 or more in the last year) History of allergy to SGLT-2 inhibitor History of bladder cancer or prior pelvic radiation More than one hypoglycemic events in the past 6 months and/or HbA1c <7.0% Women lactating or pregnant. All women with childbearing potential will undergo a blood pregnancy test at each visit to exclude pregnancy. Treatment with an investigational product within the last 30 days. Clinically evident major illness of other organ systems, including clinically evident cancer, renal failure (GFR<60 mL/min), or other conditions that in the opinion of the principal investigator make a clinical study inappropriate